Humacyte, Inc. SEC filings HUMA

Humacyte, Inc. has 504 filings in SEC EDGAR's recent list, going back to Aug 4, 2020. Its latest annual report, Form 10-K, was filed on Mar 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 28, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.

Humacyte, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Oct 7, 2026 Oct 6, 2026
4 Insider transaction Oct 7, 2026 Oct 6, 2026
3 Initial insider ownership Sep 28, 2026 Sep 22, 2026
3 Initial insider ownership Sep 28, 2026 Sep 22, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 28, 2026 Sep 22, 2026
4 Insider transaction Sep 15, 2026 Sep 14, 2026
25-NSE Delisting notice Aug 25, 2026 —
4 Insider transaction Aug 21, 2026 Aug 20, 2026
4 Insider transaction Aug 19, 2026 Aug 17, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 18, 2026 —
10-Q Quarterly report Aug 12, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 12, 2026 Aug 12, 2026
8-K Current report
Listing notice
Jul 31, 2026 Jul 31, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 28, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Jul 13, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jun 22, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Jun 15, 2026 —
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
4 Insider transaction Jun 12, 2026 Jun 11, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Jun 11, 2026 Jun 10, 2026
424B5 Prospectus supplement Jun 11, 2026 —
424B5 Prospectus supplement Jun 10, 2026 —
8-K Current report
Other events
Jun 10, 2026 Jun 10, 2026
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 9, 2026 Jun 9, 2026
8-K Current report
Other events
Jun 5, 2026 Jun 5, 2026
4 Insider transaction May 20, 2026 May 19, 2026
4 Insider transaction May 20, 2026 May 18, 2026
4 Insider transaction May 20, 2026 May 18, 2026
4 Insider transaction May 20, 2026 May 18, 2026
144 Notice of proposed sale May 18, 2026 —
144 Notice of proposed sale May 18, 2026 —
S-8 Employee stock plan registration May 14, 2026 —
10-Q Quarterly report May 13, 2026 Mar 31, 2026
8-K Current report
Listing notice
May 8, 2026 May 4, 2026
DEF 14A Proxy statement Apr 28, 2026 Apr 28, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Apr 27, 2026 —
8-K Current report
Material agreement, Regulation FD disclosure
Apr 24, 2026 Apr 21, 2026
PRE 14A Preliminary proxy statement Apr 17, 2026 Apr 17, 2026
10-K Annual report Mar 27, 2026 Dec 31, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 24, 2026 —
8-K Current report
Material agreement, Regulation FD disclosure
Mar 19, 2026 Mar 19, 2026
424B3 Prospectus Mar 19, 2026 —
8-K Current report
Results of operations, Other events
Mar 19, 2026 Mar 19, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Jan 9, 2026 —
8-K Current report
Material agreement
Dec 16, 2025 Dec 16, 2025
424B5 Prospectus supplement Dec 16, 2025 —
8-K Current report
Material agreement, New debt, Unregistered share sale
Dec 15, 2025 Dec 15, 2025
8-K Current report
Agreement ended
Dec 15, 2025 Dec 15, 2025
424B3 Prospectus Dec 15, 2025 —
4 Insider transaction Dec 8, 2025 Aug 26, 2021
8-K Current report
Agreement ended
Nov 26, 2025 Nov 21, 2025
4 Insider transaction Nov 17, 2025 Nov 16, 2025
4 Insider transaction Nov 17, 2025 Nov 16, 2025
4 Insider transaction Nov 17, 2025 Nov 16, 2025
4 Insider transaction Nov 17, 2025 Nov 16, 2025
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 12, 2025 Nov 12, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Oct 16, 2025 —
8-K Current report
Material agreement, Regulation FD disclosure
Oct 7, 2025 Oct 6, 2025
424B3 Prospectus Oct 7, 2025 —
EFFECT Filing Sep 22, 2025 —
424B3 Prospectus Sep 22, 2025 —
CORRESP Letter to the SEC Sep 18, 2025 —
8-K Current report
Material agreement, New debt
Sep 18, 2025 Sep 17, 2025
UPLOAD Letter from the SEC Sep 17, 2025 —
S-3 Shelf registration Sep 12, 2025 —
4 Insider transaction Aug 20, 2025 Aug 18, 2025
4 Insider transaction Aug 20, 2025 Aug 18, 2025
144 Notice of proposed sale Aug 20, 2025 —
144 Notice of proposed sale Aug 19, 2025 —
144 Notice of proposed sale Aug 18, 2025 —
10-Q Quarterly report Aug 11, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 11, 2025 Aug 11, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 11, 2025 Jun 10, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) May 22, 2025 —
10-Q Quarterly report May 13, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 13, 2025 May 13, 2025
DEFA14A Additional proxy material Apr 29, 2025 —
DEF 14A Proxy statement Apr 29, 2025 Jun 10, 2025
8-K Current report
Regulation FD disclosure
Apr 18, 2025 Apr 17, 2025
PRE 14A Preliminary proxy statement Apr 17, 2025 Jun 10, 2025
4 Insider transaction Apr 15, 2025 Apr 14, 2025
4 Insider transaction Apr 14, 2025 Apr 10, 2025
4 Insider transaction Apr 14, 2025 Apr 10, 2025
4 Insider transaction Apr 8, 2025 Apr 8, 2025
4 Insider transaction Apr 8, 2025 Apr 8, 2025
4 Insider transaction Apr 8, 2025 Apr 7, 2025
S-8 Employee stock plan registration Mar 31, 2025 —
10-K Annual report Mar 31, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 28, 2025 Mar 28, 2025
8-K Current report
Regulation FD disclosure
Mar 27, 2025 Mar 27, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Mar 26, 2025 Mar 25, 2025
424B5 Prospectus supplement Mar 26, 2025 —
424B3 Prospectus Mar 25, 2025 —
8-K Current report
Other events
Mar 25, 2025 Mar 25, 2025
4 Insider transaction Jan 23, 2025 Jan 21, 2025
4 Insider transaction Jan 23, 2025 Jan 21, 2025
4 Insider transaction Jan 23, 2025 Jan 21, 2025
4 Insider transaction Jan 23, 2025 Jan 21, 2025
4 Insider transaction Jan 23, 2025 Jan 21, 2025
4 Insider transaction Jan 23, 2025 Jan 21, 2025
4 Insider transaction Jan 23, 2025 Jan 21, 2025
4 Insider transaction Dec 20, 2024 Dec 19, 2024
4 Insider transaction Dec 20, 2024 Dec 19, 2024
4 Insider transaction Dec 20, 2024 Dec 19, 2024
4 Insider transaction Dec 20, 2024 Dec 19, 2024
8-K Current report
Regulation FD disclosure, Other events
Dec 20, 2024 Dec 19, 2024
4 Insider transaction Dec 4, 2024 Dec 4, 2024
4 Insider transaction Nov 21, 2024 Nov 19, 2024
4 Insider transaction Nov 21, 2024 Nov 19, 2024
SC 13D/A Amended ownership over 5% (active) Nov 20, 2024 —
4 Insider transaction Nov 20, 2024 Nov 18, 2024
4 Insider transaction Nov 20, 2024 Nov 18, 2024
144 Notice of proposed sale Nov 20, 2024 —
144 Notice of proposed sale Nov 19, 2024 —
144 Notice of proposed sale Nov 18, 2024 —
SC 13D/A Amended ownership over 5% (active) Nov 18, 2024 —
8-K Current report
Material agreement, Regulation FD disclosure
Nov 14, 2024 Nov 13, 2024
424B3 Prospectus Nov 14, 2024 —
10-Q Quarterly report Nov 8, 2024 Sep 30, 2024
SC 13G Ownership over 5% (passive) Nov 8, 2024 —
8-K Current report
Results of operations
Nov 8, 2024 Nov 8, 2024
8-K Current report
Other events
Oct 28, 2024 Oct 28, 2024
SC 13G Ownership over 5% (passive) Oct 24, 2024 —
8-K Current report
Material agreement, Regulation FD disclosure
Oct 7, 2024 Oct 4, 2024
424B3 Prospectus Oct 4, 2024 —
424B3 Prospectus Sep 25, 2024 —
8-K Current report
Material agreement
Sep 25, 2024 Sep 24, 2024
4 Insider transaction Sep 16, 2024 Sep 13, 2024
4 Insider transaction Sep 11, 2024 Sep 10, 2024
4 Insider transaction Sep 11, 2024 Sep 9, 2024
4 Insider transaction Sep 11, 2024 Sep 9, 2024
144 Notice of proposed sale Sep 10, 2024 —
144 Notice of proposed sale Sep 10, 2024 —
144 Notice of proposed sale Sep 9, 2024 —
4 Insider transaction Sep 3, 2024 Aug 29, 2024
4 Insider transaction Sep 3, 2024 Aug 29, 2024
SC 13D/A Amended ownership over 5% (active) Sep 3, 2024 —
4 Insider transaction Aug 29, 2024 Aug 27, 2024
4 Insider transaction Aug 29, 2024 Aug 27, 2024
4 Insider transaction Aug 29, 2024 Aug 27, 2024
144 Notice of proposed sale Aug 29, 2024 —
144 Notice of proposed sale Aug 28, 2024 —
144 Notice of proposed sale Aug 27, 2024 —
144 Notice of proposed sale Aug 27, 2024 —
4 Insider transaction Aug 15, 2024 Aug 15, 2024
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
UPLOAD Letter from the SEC Aug 13, 2024 —
8-K Current report
Results of operations, Other events
Aug 13, 2024 Aug 9, 2024
CORRESP Letter to the SEC Aug 6, 2024 —
8-K Current report
Other events
Jul 31, 2024 Jul 31, 2024
UPLOAD Letter from the SEC Jul 23, 2024 —
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
4 Insider transaction Jun 17, 2024 Jun 13, 2024
3 Initial insider ownership Jun 17, 2024 Jun 11, 2024
3 Initial insider ownership Jun 17, 2024 Jun 11, 2024
8-K Current report
Officer or director change, Shareholder vote results
Jun 13, 2024 Jun 11, 2024
4 Insider transaction Jun 13, 2024 Jun 11, 2024
4 Insider transaction Jun 13, 2024 Jun 11, 2024
144 Notice of proposed sale Jun 12, 2024 —
4 Insider transaction Jun 4, 2024 Jun 4, 2024
4 Insider transaction Jun 4, 2024 Jun 4, 2024
SC 13D/A Amended ownership over 5% (active) Jun 4, 2024 —
4 Insider transaction Jun 4, 2024 May 31, 2024
4 Insider transaction Jun 4, 2024 May 31, 2024
144 Notice of proposed sale Jun 4, 2024 —
4 Insider transaction Jun 3, 2024 Jun 3, 2024
4 Insider transaction Jun 3, 2024 Jun 3, 2024
4 Insider transaction Jun 3, 2024 May 30, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
HUMA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Durham, NC
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1818382
Former names
Alpha Healthcare Acquisition Corp. (until Aug 26, 2021)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.